Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RPRX | AZN | AMGN | GILD | BMY |
| Company | Royalty Pharma Plc Cl A | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 46.37 | 193.91 | 373.51 | 145.11 | 59.17 |
| High | 46.49 | 193.92 | 375.00 | 146.95 | 59.38 |
| Low | 45.63 | 190.96 | 367.76 | 143.89 | 58.32 |
| Latest | 45.87 | 192.50 | 367.79 | 145.21 | 58.95 |
| Change | -0.82 | -0.81 | -9.85 | -0.79 | -1.03 |
| % Change | -1.76% | -0.42% | -2.61% | -0.54% | -1.72% |
| Volume | 3,834,800 | 2,154,700 | 1,990,600 | 7,006,700 | 10,235,101 |
| 20-Day Average Volume | 3,512,530 | 2,077,440 | 2,559,845 | 6,873,900 | 12,524,359 |
| Previous Close | 46.69 | 193.31 | 377.64 | 146.00 | 59.98 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 45.82 | 202.27 | 376.49 | 148.81 | 60.79 |
| 20-Day Raw Stochastic | 47.77% | 13.48% | 21.39% | 17.21% | 13.80% |
| 20-Day Relative Strength | 59.73 | 46.39 | 51.63 | 52.33 | 50.27 |
| Weighted Alpha | +44.74 | +28.84 | +24.64 | +36.59 | +11.18 |
| Today's Opinion | 100% Buy | 56% Buy | 88% Buy | 88% Buy | 80% Buy |
| Previous Opinion | 100% Buy | 64% Buy | 100% Buy | 88% Buy | 88% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.42% since 03/05/26 | -2.54% since 03/05/26 | +0.05% since 03/05/26 | +0.05% since 03/05/26 | -2.95% since 03/05/26 |
| Low | 44.94 on 03/06/26 | 189.35 on 03/09/26 | 361.70 on 03/06/26 | 142.77 on 03/06/26 | 58.32 on 03/12/26 |
| High | 46.82 on 03/11/26 | 198.09 on 03/10/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 60.96 on 03/10/26 |
| 1-Month | |||||
| %Chg | +2.39% since 02/12/26 | -5.88% since 02/12/26 | +0.43% since 02/12/26 | -4.35% since 02/12/26 | -1.52% since 02/12/26 |
| Low | 44.67 on 02/20/26 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 58.32 on 03/12/26 |
| High | 47.86 on 03/04/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.95 on 02/13/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +19.48% since 12/12/25 | +7.15% since 12/12/25 | +15.75% since 12/12/25 | +20.61% since 12/12/25 | +12.48% since 12/12/25 |
| Low | 37.83 on 12/16/25 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 47.86 on 03/04/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +26.16% since 09/12/25 | +20.98% since 09/12/25 | +33.07% since 09/12/25 | +26.77% since 09/12/25 | +27.60% since 09/12/25 |
| Low | 34.63 on 09/26/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 47.86 on 03/04/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 26,460,430 | 298,549,792 | 198,263,824 | 180,266,752 | 120,050,144 |
| Shares Outstanding, K | 576,857 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 2,378,190,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | 770,950,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 621,990,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 214,210,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.40 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.17 on 11/05/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/14/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | 0.235 on 02/20/26 | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | 02/20/26 | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 9.67 | 21.10 | 17.28 | 17.91 | 9.75 |